Windtree Therapeutics, Inc.
WINT
$0.05
$0.00-5.74%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -311.97% | -28.76% | -169.27% | 91.19% | 60.90% |
| Total Depreciation and Amortization | 106.79% | -145.45% | -496.25% | -481.71% | -156.23% |
| Total Amortization of Deferred Charges | -886.05% | -220.00% | -- | -- | -- |
| Total Other Non-Cash Items | 460.01% | 75.66% | 96.69% | -412.49% | -163.33% |
| Change in Net Operating Assets | -53.59% | -71.72% | -34.30% | -32.06% | 413.33% |
| Cash from Operations | 1.07% | -19.69% | -7.19% | -14.62% | -15.35% |
| Capital Expenditure | 100.00% | 100.00% | 20.00% | 20.00% | 20.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -49,666.67% | -19,096.30% | 20.00% | 20.00% | 20.00% |
| Total Debt Issued | 157.95% | 366.06% | -- | -- | -- |
| Total Debt Repaid | -257.54% | -115.00% | 5.14% | -1.00% | 1.28% |
| Issuance of Common Stock | 99.81% | 637.04% | 17.68% | 15.21% | -20.65% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -574.97% | -- | -- | -- | -- |
| Total Dividends Paid | -15.27% | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 159.52% | 132.00% | -- | -- |
| Cash from Financing | 88.28% | 547.29% | 12.14% | 9.81% | -17.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 59.76% | 84.69% | 25.41% | -44.37% | -384.28% |